Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Experimental Gerontology

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.EXGER.2004.07.006PMID 15501028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease

  2006cited by this paper
• Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles.

  2004cited by this paper
• Regional European differences in allele and genotype frequencies of low density lipoprotein receptor‐related protein 1 polymorphism in Alzheimer's disease

  2004cited by this paper
• Interleukin‐6–174 G/C Promoter Gene Polymorphism C Allele Reduces Alzheimer's Disease Risk

  2003cited by this paper
• Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

  2003cited by this paper
• Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain.

  2003cited by this paper
• Crohn’s associated NOD2 gene variants are not involved in determining susceptibility to multiple sclerosis

  2003cited by this paper
• -174 G/C interleukin-6 gene polymorphism and increased risk of multi-infarct dementia: a case-control study.

  2002cited by this paper
• Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.

  2002cited by this paper
• The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected].

  2002cited by this paper
• Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease

  2002cited by this paper
• Genetics of interleukin 6: implications for Alzheimer's disease.

  2001cited by this paper
• Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.

  2000cited by this paper
• Apolipoprotein E in Southern Italy: protective effect of ε2 allele in early- and late-onset sporadic Alzheimer's disease

  2000cited by this paper
• Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis.

  2000cited by this paper
• Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease.

  2000cited by this paper
• Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease.

  2000cited by this paper
• Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians.

  1999cited by this paper
• Decreased frequency of apolipoprotein E ε4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians

  1999cited by this paper
• Microglial Activation in Alzheimer Disease: Association with APOE Genotype

  1998cited by this paper
• The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

  1998cited by this paper
• Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies.

  1997cited by this paper
• The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease.

  1996cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Cytokines in Alzheimer's disease.

  1991cited by this paper
• Apolipoprotein E polymorphism and atherosclerosis.

  1988cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Diagnostic evaluation of degenerative and vascular dementia.

  1983cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Exploring the Link Between IL-6 rs1800795 G > C SNP and the Severity of Epstein-Barr Virus-Associated Multiple Sclerosis: Potential Impact on Cognitive Impairment

  2025cites this paper
• Increased Frequencies of the ‒174G and ‒572C IL6 Alleles in Populations of Indigenous Peoples of Siberia Compared to Russians

  2023cites this paper
• Increased Frequencies of the ‒174G and ‒572C IL6 Alleles in Populations of Indigenous Peoples of Siberia Compared to Russians

  2023cites this paper
• Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation

  2023cites this paper
• Increased Frequencies of ‒174G and ‒572C IL6 Alleles in Populations of Indigenous Peoples of Siberia Compared to Russians

  2023cites this paper
• Genes Involved in DNA Damage Cell Pathways and Health of the Oldest-Old (85+)

  2023cites this paper
• Isorhamnetin Attenuated the Release of Interleukin-6 from β-Amyloid-Activated Microglia and Mitigated Interleukin-6-Mediated Neurotoxicity

  2022cites this paper
• Genetic predictors of cytokine response in ENT-associated encephalitis

  2021cites this paper
• IL-1β, IL-6, IL-10, and TNFα single nucleotide polymorphisms are associated with cerebrospinal �uid levels of biomarkers of Alzheimer’s disease

  2021cites this paper
• Alzheimer’s Disease: A Neurodegenerative Menace of Elderly

  2021cites this paper
• ApoE ε4 and IL-6-174G/C Polymorphism may Lead to Early Onset of Alzheimer's Disease with Atypical Presentation

  2021cites this paper
• IL-1β, IL-6, IL-10, and TNFα Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer’s Disease Pathology

  2020cites this paper
• IL-1β, IL-6, IL-10, and TNFα single nucleotide polymorphisms are associated with cerebrospinal fluid levels of biomarkers of Alzheimer’s disease

  2019cites this paper
• Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease via Peroxisome Proliferator-Activated Receptor α

  2019cites this paper
• Interleukin-6 Gene Promoter Region Polymorphism in Patients with Dilated Cardiomyopathy

  2019cites this paper
• Association of Per3 length polymorphism with susceptibility of Alzheimer disease (AD) in Chinese population

  2018influential citation
• Epigenetic regulation of interleukin 6 in age-related cognitive decline and Alzheimer's disease

  2018cites this paper
• Association of pro-inflammatory cytokines gene polymorphisms with Alzheimer ’ s disease susceptibility in the Han Chinese population

  2017cites this paper
• Interleukin-6 Genetic Variation and Susceptibility to Gastric Cancer in an Iranian Population

  2017cites this paper
• Neuroinflammatory genes associated with post-traumatic stress disorder: implications for comorbidity

  2017cites this paper
• Association between interleukin 6 -174 G/C promoter gene polymorphism and runners' responses to the dietary ingestion of antioxidant supplementation based on pequi (Caryocar brasiliense Camb.) oil: a before-after study

  2016cites this paper
• Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis

  2016cites this paper
• Interleukin-6-174 Promoter Polymorphism and Susceptibility to Hepatitis B Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Iran.

  2016cites this paper
• Serum Procalcitonin and Proinflammatory markers in Polycystic Ovary Syndrome

  2016cites this paper
• Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer’s Disease

  2016cites this paper
• TNF-alpha G308A polymorphism and the susceptibility to Alzheimer's disease: an updated meta-analysis.

  2015cites this paper
• IL-6 genotype and the susceptibility to Alzheimer's disease

  2015cites this paper
• Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges

  2015cites this paper
• Genetic factors in traumatic brain injury.

  2015cites this paper
• Meta-analysis of PvuII, XbaI variants in ESR1 gene and the risk of Alzheimer's disease: the regional European difference.

  2014cites this paper
• Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.

  2014cites this paper
• Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer

  2014cites this paper
• Association of IL-6 (-174)G>C Genetic Polymorphism to Glycemic Status and Plasma CRP in Pre-Diabetes and Type 2 Diabetes Mellitus in a Filipino Population

  2014cites this paper
• Allele frequency distributions of -174G/C polymorphism in regulatory region of interleukin 6 gene (IL6) in Russian and worldwide populations

  2013influential citation
• Ethnic Variation in Interleukin-6 –174 (G/C) Polymorphism in the Malaysian Population

  2013cites this paper
• Association Between Interleukin 6 Gene Haplotype and Alzheimer's Disease: A Brazilian Case-Control Study

  2013cites this paper
• Polymorphism of CLOCK gene rs 4580704 C > G is associated with susceptibility of Alzheimer's disease in a Chinese population.

  2013cites this paper
• Role of Interleukin 6–174G>C Polymorphism in Primary Open-Angle Glaucoma

  2013cites this paper
• Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer’s disease: a meta-analysis

  2012cites this paper
• IL-6-174 G/C and -572 C/G Polymorphisms and Risk of Alzheimer’s Disease

  2012cites this paper
• Microglia Function in Alzheimer’s Disease

  2012influential citation
• Méthodes pour traiter, diagnostiquer et surveiller la maladie d'alzheimer

  2012cites this paper
• Interleukin 6–174G>C polymorphism and risk of aneurysmal subarachnoid hemorrhage: case–control study and meta‐analysis

  2012influential citation
• The combination of ınterleukin-10 -1082 and tumor necrosis factor α -308 or ınterleukin-6 -174 genes polymorphisms suggests an association with susceptibility to Hashimoto's thyroiditis.

  2012cites this paper
• MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction.

  2012cites this paper
• Interleukin-6, a Major Cytokine in the Central Nervous System

  2012cites this paper
• Cytokines and Alzheimer’s Disease

  2011cites this paper
• Has dysregulated interleukin-6 gene a role in the development of Alzheimer's disease?

  2011cites this paper
• Variantes génicas asociadas a neuroinflamación en la enfermedad de Alzheimer en Canarias

  2011cites this paper
• Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease

  2011cites this paper
• Inflammatory risk factors and pathologies associated with Alzheimer's disease.

  2011cites this paper
• Interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: a meta-analysis.

  2011cites this paper
• Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.

  2010influential citation
• The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE epsilon 4 carriers.

  2010cites this paper
• Association between an intronic apolipoprotein E polymorphism and bone mineral density in Singaporean Chinese females.

  2010cites this paper
• Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications.

  2010cites this paper
• Inflammation-associated risk factors for Alzheimer s disease and dementia

  2010cites this paper
• Interleukin-6 gene (-174 C/G ) and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population.

  2010influential citation
• Genetic Factors Modulating Outcome After Neurotrauma

  2010cites this paper
• Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility.

  2009cites this paper
• The combinations of TNFα–308 and IL‐6 –174 or IL‐10 –1082 genes polymorphisms suggest an association with susceptibility to sporadic late‐onset Alzheimer’s disease

  2009influential citation
• Epistasis in sporadic Alzheimer's disease.

  2009cites this paper
• Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study.

  2008cites this paper
• Interleukin 6 gene polymorphisms are not associated with aneurysmal subarachnoid haemorrhage in an Italian population

  2008cites this paper
• Cytokine IL‐1 beta but not IL‐1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain

  2008cites this paper
• Association between genetic variants of IL-1β, IL-6 and TNF-α cytokines and cognitive performance in the elderly general population of the MEMO-study

  2008cites this paper
• Zinc–gene interaction related to inflammatory/immune response in ageing

  2008cites this paper
• CHAPTER 16 – The Role of Pro-inflammatory Cytokines in Memory Processes and Neural Plasticity

  2007cites this paper
• Risk factors for hypospadias in the estrogen receptor 2 gene.

  2007cites this paper
• COMPLEX GENETIC DISORDER

  2007cites this paper
• The Genetics of Innate Immunity and Inflammation in Ageing, Age-Related Diseases and Longevity

  2007cites this paper
• Hypospadias : Analysis of a complex genetic disorder

  2007cites this paper
• Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision.

  2007cites this paper
• Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study.

  2006cites this paper
• Genetic Components of Late-Onset Alzheimer's Disease with Special Emphasis on ApoE, IL- 6, CYP46, SERPINA3 and PPARγ

  2006cites this paper
• Interleukins, inflammation, and mechanisms of Alzheimer's disease.

  2006cites this paper
• Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study.

  2006cites this paper
• The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations.

  2005cites this paper
• INTERLEUKIN-6 PROMOTER POLYMORPHISM AND LATE-ONSET ALZHEIMER's DISEASE IN THE FINNISH POPULATION

  2005influential citation